MicroVision's SEC filings document material events for a lidar-based perception company serving automotive, industrial, and security and defense markets. Current reports describe operating results, business updates, investor presentations, and product and market disclosures tied to the company's lidar sensor portfolio and perception software.
Recent filings also record the completed acquisition of certain Luminar lidar sensor business assets, including required historical financial statements and unaudited pro forma financial information. Other disclosures cover senior secured convertible notes due 2028, exchanges and purchases of convertible debt, direct common stock sales to directors and executive officers, Nasdaq-related share issuance considerations, governance matters, and Regulation FD communications.
MICROVISION, INC. (MVIS) director Peter Schabert reported the vesting and exercise of 4,670 Restricted Stock Units into an equal number of shares of common stock on September 1, 2026. The RSUs converted to common stock on a unit-for-share basis without payment, bringing his direct common stock holdings to 15,902 shares. No Rule 10b5-1 trading plan is reported for these transactions.
MicroVision, Inc. (MVIS) announced that it has regained compliance with Nasdaq’s continued listing requirements. On August 26, 2026, Nasdaq Listing Qualifications informed the company that it now complies with Listing Rule 5550(a)(2), which requires a minimum bid price of at least $1 per share. MicroVision had previously received a noncompliance notice on January 12, 2026, but Nasdaq has now stated that the matter is closed.
MicroVision, Inc. completed a registered public offering of 6,800,000 shares of common stock together with warrants to purchase 6,800,000 shares. The securities were sold as units at a combined offering price of $2.50 per share and accompanying warrant, generating gross proceeds of $17.0 million and net proceeds of approximately $15.6 million after fees and expenses, excluding any future warrant exercises.
The warrants are immediately exercisable at $2.50 per share and remain exercisable for five years from closing. WestPark Capital, Inc. acted as sole placement agent on a reasonable best efforts basis, receiving a 6.5% cash commission and $115,000 in expense reimbursement. MicroVision plans to use the net proceeds for general corporate purposes, including working capital and capital expenditures.
For 45 days after closing, the company agreed not to issue additional common equity or price-reset securities (with limited exceptions), and not to make additional repayments on its senior secured convertible notes maturing March 1, 2028.
MicroVision, Inc. is conducting a primary offering of 6,800,000 shares of common stock together with 6,800,000 Common Warrants, with each share sold with one warrant at a combined public offering price of $2.50. The warrants are immediately exercisable at $2.50 per share and expire five years after issuance. Gross proceeds are expected to be $17.0 million, with estimated net proceeds of approximately $15.6 million after placement fees and expenses, excluding any proceeds from warrant exercises. Shares outstanding will increase from 23,350,027 to 30,150,027 after the offering, before any warrant exercise. MicroVision plans to use the net proceeds for general corporate purposes, including working capital and capital expenditures.
MICROVISION, INC. officer Jeemyung Byun, serving as Chief Commercial Officer, filed an initial statement of beneficial ownership on Form 3. The report lists no equity transactions and shows no holdings or derivative positions in the company’s securities as of the filing.
MicroVision, Inc. is conducting a primary offering of common stock, Pre-Funded Warrants and five-year Common Warrants under its $50,000,000 shelf registration. Each share of common stock (or Pre-Funded Warrant) is sold together with one Common Warrant, with the mix between shares and Pre-Funded Warrants driven by beneficial ownership limits of 4.99% or 9.99% of outstanding stock. The deal is a best-efforts placement through WestPark Capital, which will receive a 6.5% cash fee on gross proceeds and expense reimbursement, and there is no minimum amount required to close. MicroVision plans to use net proceeds for general corporate purposes, including working capital and capital expenditures. The company recently effected a 1-for-15 reverse stock split and reduced authorized common stock to 150,000,000 shares, and has a history of operating losses funded largely through equity and convertible securities. The filing highlights potential dilution, stock-price volatility, lack of a trading market for the Warrants and the absence of any current dividend policy.
MicroVision, Inc. appointed Christine Chambers as Chief Financial Officer and principal financial and accounting officer, effective August 27, 2026. She brings more than two decades of financial leadership across public and high-growth technology companies, including prior CFO roles at Fusemachines, PetMed Express, and RealNetworks.
Her compensation package includes an annual base salary of $425,000, a target annual bonus of 65% of base salary, a one-time new-hire RSU award valued at $1,000,000 vesting over four years, and an annual long-term RSU opportunity valued at $800,000 vesting over three years, all subject to continued employment and equity plan terms. Three months after her start date, she will participate in MicroVision’s Key Executive Severance and Change in Control Plan as a Tier 2 Executive. Interim CFO Stephen Hrynewich will step down from the interim role on the Effective Date but remain in a senior finance role; his transition is stated not to result from any disagreement regarding the company’s operations, policies, or practices.
MicroVision, Inc. reported Q2 2026 revenue of $1,473 thousand, up from $155 thousand a year earlier, driven by IRIS long-range and MOVIA L short-range lidar sensor shipments plus contract and license revenue. Q2 gross profit was $642 thousand.
Operating expenses rose to $24,853 thousand, reflecting higher R&D, acquisition-related costs from the Luminar and Scantinel deals, and restructuring as engineering and manufacturing are consolidated into Orlando. Q2 net loss was $36,943 thousand, and first-half 2026 net loss was $62,237 thousand.
Cash and cash equivalents were $27,208 thousand at June 30, 2026, with net cash used in operating activities of $35,588 thousand in the first half. The company had $27,036 thousand of senior secured convertible notes outstanding and a related $7,050 thousand derivative liability, plus a $380 thousand warrant liability, and access to approximately $41.2 million of remaining at-the-market equity capacity. Management states that high cash burn, increased expenses from the Luminar acquisition, and current liquidity conditions raise substantial doubt about the ability to continue as a going concern through at least twelve months from issuance of these financial statements, despite ongoing financing and cost-reduction plans and a 1-for-15 reverse stock split completed in August 2026.
MicroVision, Inc. reported second quarter 2026 revenue of $1.47 million and a net loss of $36.94 million, or $1.66 per share, compared with revenue of $0.16 million and a net loss of $14.23 million a year earlier. Gross profit turned positive at $0.64 million, but operating expenses of $24.85 million led to a larger operating loss.
For the first half of 2026, revenue was $2.41 million and adjusted EBITDA was a loss of $36.03 million. Cash, cash equivalents and restricted cash totaled $28.87 million as of June 30, 2026, and the company states it has access to $68.4 million of capital, including $41.2 million under an at-the-market facility. Management highlighted a long-term development agreement with a leading construction and mining OEM to integrate its IRIS lidar into autonomous hauling vehicles and ongoing evaluations with customers in AI, e‑commerce logistics, defense and robotics as part of its Lidar 2.0 strategy.
BlackRock, Inc. filed an amended Schedule 13G reporting beneficial ownership of 3,430,821 shares of MicroVision, Inc. common stock, representing 1.0% of the class. BlackRock reports sole voting and dispositive power over all of these shares, with no shared voting or dispositive authority.
The filing notes that various persons have the right to receive dividends or sale proceeds from these shares, but no single person’s interest exceeds five percent of MicroVision’s total outstanding common shares.